Eventide Asset Management LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,313 shares of the medical equipment provider's stock after buying an additional 701 shares during the quarter. Eventide Asset Management LLC's holdings in Intuitive Surgical were worth $28,876,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. AlphaCore Capital LLC lifted its stake in shares of Intuitive Surgical by 4.2% in the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after buying an additional 18 shares during the last quarter. Second Line Capital LLC lifted its stake in shares of Intuitive Surgical by 3.4% in the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after buying an additional 19 shares during the last quarter. Colonial Trust Co SC lifted its stake in shares of Intuitive Surgical by 8.8% in the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock worth $128,000 after buying an additional 20 shares during the last quarter. Crown Wealth Group LLC lifted its stake in shares of Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after buying an additional 20 shares during the last quarter. Finally, FSM Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock worth $270,000 after buying an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on ISRG shares. Piper Sandler restated an "overweight" rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Royal Bank Of Canada restated an "outperform" rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Finally, Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $595.95.
Check Out Our Latest Report on Intuitive Surgical
Intuitive Surgical Price Performance
ISRG stock traded up $3.14 on Monday, reaching $470.00. 1,936,330 shares of the company were exchanged, compared to its average volume of 2,023,255. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock's fifty day moving average price is $494.00 and its 200 day moving average price is $512.08. The firm has a market capitalization of $168.49 billion, a PE ratio of 65.55, a PEG ratio of 4.89 and a beta of 1.61.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business's revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.78 EPS. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company's stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 in the last 90 days. 0.70% of the stock is currently owned by company insiders.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.